RSV testing among infants has increased since 2015, with significant growth post-COVID-19, yet outpatient testing remains low. The study analyzed 20,752 bronchiolitis encounters across four healthcare ...
Researchers in France conducted a multicentre test‑negative case-control study to evaluate the effectiveness of nirsevimab in preventing RSV‑associated bronchiolitis at paediatric emergency ...
CXCL12 and CXCL13 are potential biomarkers for RSV bronchiolitis severity and recurrence risk, with elevated levels indicating severe cases and recurrent wheezing, respectively. RSV remains a major ...
Immunisation with nirsevimab reduced bronchiolitis-related hospitalisations among infants younger than 3 months who visited the emergency department (ED), according to a new study. Nirsevimab also ...
An investigational oral antiviral drug eased bronchiolitis and was safe for children 2 years and younger hospitalized with respiratory syncytial virus (RSV) infection, according to a phase III trial ...
Bronchiolitis, primarily caused by RSV, is a serious respiratory condition in infants that can lead to severe mucus build-up and breathing difficulties. Pediatrician Cindy Gellner, MD explains how ...
Morning Overview on MSN
The FDA approved a Pfizer RSV vaccine for at-risk adults as young as 18
Adults between 18 and 59 who face elevated risk of severe respiratory syncytial virus infection now have a licensed vaccine ...
Respiratory syncytial virus (RSV) is a common virus that can cause severe respiratory illness in infants and young children, including lower respiratory tract infections (LRTIs) such as bronchiolitis ...
For infants and young children hospitalized with respiratory syncytial virus (RSV) infection, ziresovir reduces signs and symptoms of bronchiolitis, according to a study published in the Sept. 26 ...
A new UK study shows that vaccinating pregnant women against RSV has led to a staggering 72% drop in hospitalizations of newborns with severe lung infections. By passing virus-fighting antibodies to ...
A quarter to half of healthy infants born at term are infected with RSV in the first year of life, and 2-3% have small airway bronchiolitis and lower respiratory tract infection that requires hospital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results